28 studies found for:    apatinib
Show Display Options
Rank Status Study
1 Recruiting Apatinib for Metastatic Esophageal Cancer.
Conditions: Esophageal Cancer;   Metastatic Esophageal Cancer;   Apatinib
Intervention: Drug: Apatinib
2 Not yet recruiting The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Biological: Cytokine-Induced Killer Cells;   Drug: Apatinib
3 Active, not recruiting The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR
Condition: Adenocarcinoma of Lung
Interventions: Biological: Cytokine-Induced Killer Cells;   Drug: Apatinib
4 Recruiting Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Apatinib single agent arm
5 Recruiting The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: apatinib single agent
6 Not yet recruiting Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell Carcinoma
Condition: Esophageal Squamous Cell Carcinoma
Interventions: Drug: Apatinib;   Drug: Irinotecan
7 Recruiting Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: apatinib
8 Completed A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: apatinib;   Drug: placebo
9 Completed A Study of Apatinib in Non-triple-negative Metastatic Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: Apatinib
10 Recruiting Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Apatinib;   Drug: Placebo
11 Completed Study of Apatinib in Metastatic Triple-Negative Breast Cancer Patients
Condition: Metastatic Breast Cancer
Intervention: Drug: Apatinib
12 Recruiting A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer
Condition: Gastric Carcinoma
Interventions: Drug: Docetaxel;   Drug: apatinib
13 Completed A Study of Apatinib in Patients With Advanced Hepatocellular Carcinoma
Condition: Advanced Hepatocellular Carcinoma
Intervention: Drug: Apatinib
14 Not yet recruiting Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: Apatinib;   Drug: S-1
15 Unknown  Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: apatinib;   Drug: placebo
16 Unknown  Study of Apatinib as an Inhibitor of Tumor Angiogenesis
Condition: Tumor
Intervention: Drug: apatinib
17 Active, not recruiting Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: Apatinib
18 Recruiting Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: S1/Paclitaxel chemotherapy plus Apatinib
19 Completed Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer
Condition: Gastric Carcinoma
Intervention: Drug: apatinib tablet
20 Completed Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer
Condition: Advanced or Metastatic Gastric Cancer
Interventions: Drug: apatinib;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years